Live feed
Filing
SC 13D
SC 13D0001213900-24-025263·KIDRON NADAV
Schedule 13D ownership disclosure
Oramed Pharmaceuticals, Inc.
Security class unavailable · CUSIP: 68403P203
Event date: 2024-03-06
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 5.7000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-24-025263
- Form type
- SC 13D
- Filer
- KIDRON NADAV
- CIK
- CIK 1351779
- Filed
- Mar 22, 2024
- Reporting period
- Mar 06, 2024
- Description
- Schedule 13D beneficial ownership